Nifty 50 closed at 24,768.35, down by 86.70 points or 0.35%. Bank Nifty settled at 55,961.95, declining by 188.75 points or 0.34%. Sensex ended the day at 81,185.58, falling 296.28 points or 0.36%.
Global events/updates
- India is Considering Measures to calm Trump following the sudden 25% Tariff Imposed on exports.
- A high-level meeting is underway in response to the ongoing US tariff situation. Key senior cabinet ministers, including Home Minister Amit Shah, Defence Minister Rajnath Singh, JP Nadda, Kiran Rijiju, Arjun Meghwal, Prahlad Joshi, and Piyush Goyal, are participating in the discussions.
- Trump makes a U-turn statement – Tariff is 25%, not final talks on with India. Nifty, Nifty Bank turns green after gap-down opening. Short covering aggressive on expiry day.
- No Immediate Impact Of 25+% Tariffs On Smartphone, Laptop Exports From India To US.
Trump Impact on Textile Sector: Companies with High U.S. Exposure
With the looming threat of protectionist policies under Donald Trump’s potential return, Indian textile companies with significant U.S. revenue exposure may face increased risks.Companies like Himatsingka Seide (83%), Gokaldas (77%), and Indo Count (70%) derive a major share of their revenues from the U.S. market, making them highly sensitive to any trade disruptions or tariff hikes.
Other key names include Welspun Living (65%), Alok Industries (45%), and Trident (38%), followed by Arvind (35%) and KPR Mills (21%). Investors and stakeholders should monitor policy changes closely, as high U.S. exposure may translate into volatility and earnings risk.
Trump Impact on Pharma Sector with High U.S. Exposure
The potential return of Donald Trump and his protectionist trade stance could impact Indian pharma companies significantly, especially those with high revenue dependence on the U.S. market. Gland Pharma and Aurobindo Pharma lead the pack, each with 50% of their FY24 revenue coming from the U.S.
Dr. Reddy’s and Zydus Lifesciences follow closely with 45% each, while Lupin (38%), Glenmark (35%), Sun Pharma and Cipla (30% each) also hold notable exposure. Torrent Pharma, with only 9% U.S. revenue, remains relatively insulated. Policy shifts or pricing regulations in the U.S. could have meaningful implications for earnings and valuations across the sector.
Stock news
- Gillette India: Revenue grew 10% YoY, Net Profit grew 26% YoY.
- Phosphate Company: Revenue grew 77% YoY, Net Profit of Rs 79.75 lakhs from a loss of Rs 50.32 lakh YoY
- K2 Infragen Ltd: Penny Stock jumps 5% after receiving an order worth ₹29 cr for transmission project in Gurugram.
- Maruti Suzuki India: Q1 standalone net profit ₹3,710 crore vs ₹3,650 crore (YoY); estimate ₹3,078 crore.
- Q1 EBITDA Margin: 10.4% vs 12.67% (YoY); estimate 10.2%.
- MTNL: Centre plans to raise ₹4,500 crore from MTNL by selling assets.
- Dabur India: Q1 consolidated net profit ₹510 crore vs ₹500 crore (YoY); estimate ₹497 crore.
- Cyient and Zinier Announce Partnership to Accelerate Field Service Transformation.
- Nuvama Wealth: Income Tax Department is conducting searches in the Jane Street issue. The department is conducting searches on Jane Street and Nuvama Broking.
Top gainer/Top loser (Nifty 500)
| Top gainers | Top losers |
| Sagility India Ltd. (10.0%) | Apar Industries Ltd. (-8.4%) |
| Kaynes Technology India Ltd. (9.5%) | IIFL Finance Ltd. (-6.4%) |
| HEG Ltd. (6.7%) | Indus Towers Ltd. (-5.8%) |
| Emami Ltd. (6.0%) | Hindustan Copper Ltd. (-5.8%) |
| Schneider Electric Infrastructure Ltd. (5.0%) | Aarti Industries Ltd. (-5.7%) |
Conclusion
Indian markets closed in the red amid global trade concerns, with Nifty, Sensex, and Bank Nifty posting modest declines, reflecting cautious investor sentiment. Despite initial market jitters triggered by the announcement of a sudden 25% US tariff, Indian indices managed to limit their losses, supported by strong short covering on expiry day. Trump’s clarification that the tariff is “not final” and that talks are ongoing with India has helped ease some tension.
Written by Manideep Appana
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Closing Bell: Sagility India, Kaynes Tech among top gainers as Nifty closes at 24,768; Sensex declines 296 points appeared first on Trade Brains.